Comprehensive genomic profiling for cancer

Decoding the differences of cancer at a genomic level is key to precision oncology. Agilent's SureSelect Cancer Comprehensive Genomic Profiling (CGP) Assay and workflow detects biomarkers from solid tumors by profiling clinically relevant genes and assessing key classes of mutations to gain insights into tumors. The assay features fast hybridization, low sample input, enzymatic fragmentation, and a one-day workflow to generate NGS sequencing-ready libraries.